SCHEMBL29613365

SCHEMBL29613365

c1ccc2c(c1)ccc1ccc3ccc4ccccc4c3c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.72
ALDH1A1 P00352 7/20 0.72
CYP1A2 P05177 6/20 0.72
HPGD P15428 5/20 0.72
THRB P10828 1/20 0.72
TSHR P16473 6/20 0.69
CYP2A6 P11509 5/20 0.69
TDP1 Q9NUW8 3/20 0.69
HPRT1 P00492 1/20 0.61
HIF1A Q16665 2/20 0.55
CYP1B1 Q16678 2/20 0.55
CYP3A4 P08684 4/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
ERBB2 P04626 1/20 0.54
FYN P06241 1/20 0.54
MAOA P21397 1/20 0.54
ACHE P22303 1/20 0.54
AHR P35869 1/20 0.54
MAPK1 P28482 1/20 0.54
CASP1 P29466 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL535472 1.00 HSD17B10 (0.72) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29487823 1.00 HSD17B10 (0.72) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29568845 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29569839 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL4851942 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29453497 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29613364 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29613385 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29569225 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB
SCHEMBL29569119 0.97 HSD17B10 (0.68) HSD17B10ALDH1A1CYP1A2HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024131166-A1 NITROGEN-CONTAINING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2024-06-27 WO disclosed
US-11319266-B2 Syntheses, characterizations, and applications of heli-acenes University of Wyoming-Office of Research & Economic Development (US) 2022-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319266-B2 Syntheses, characterizations, and applications of heli-acenes HRH1, EHD1, CRY1 HSD17B10 335/4885ALDH1A1 1022/4885CYP1A2 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.